| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5842703 | Life Sciences | 2012 | 6 Pages |
Abstract
Taken together, the results of the present study indicate that ALA attenuates steatohepatitis through inhibition of several pathways, and provide the possibility that ALA can be used to prevent the development and progression of non-alcoholic fatty liver disease in patients who have strong risk factors for NASH.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ae-Kyung Min, Mi-Kyung Kim, Hye-Soon Kim, Hye-Young Seo, Ki-Up Lee, Jung-Guk Kim, Keun-gyu Park, In-Kyu Lee,